Back
Cintas Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
53
CTAS
Cintas
Last Price:
$207.35
Seasonality Move:
6.06%
Sell
25
DRUG
Bright Minds Biosciences
Last Price:
$37.50
Seasonality Move:
-32.13%
Sell
25
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $33.89. The Score for DRUG is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $33.89The current trend is relatively stagnant and DRUG is experiencing slight buying pressure.
CTAS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.58 | Buy |
Relative Strength Index (14 RSI): | 51.32 | Buy |
Chaikin Money Flow: | -1599995 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (200.06 - 205.48) | Buy |
Bollinger Bands (100): | (194.77 - 217.65) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 39.44 | Sell |
Chaikin Money Flow: | 2596 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.9 - 42.16) | Sell |
Bollinger Bands (100): | (23.98 - 48.72) | Sell |
CTAS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 205 | Sell |
20-day SMA: | 203.6 | Sell |
50-day SMA: | 197.93 | Buy |
200-day SMA: | 196.18 | Buy |
8-day EMA: | 204.6 | Sell |
20-day EMA: | 203.3 | Buy |
50-day EMA: | 202.32 | Buy |
200-day EMA: | 193.33 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.31 | Sell |
20-day SMA: | 38.38 | Sell |
50-day SMA: | 37.75 | Sell |
200-day SMA: | 18.73 | Buy |
8-day EMA: | 36.19 | Sell |
20-day EMA: | 37.52 | Sell |
50-day EMA: | 37.1 | Sell |
200-day EMA: | 24 | Buy |
Cintas Earnings Growth & CTAS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.58 per share, and an increase next year of $0.46 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Cintas Technical Analysis
Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
12 | 13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
12 | 13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |